IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020
BTIG Virtual Biotechnology Conferenceon Tuesday, August 11, 2020at 1:00 pm EST. Yujiro S. Hata, Chief Executive Officer and President, IDEAYA Biosciences, will participate in a fireside chat with Thomas Shrader, Ph.D., CFA, Equity ResearchAnalyst, BTIG Wedbush PacGrow Healthcare Virtual Conferenceon Wednesday, August 12, 2020at 8:00 am EST. Yujiro S. Hata, Chief Executive Officer and President, IDEAYA Biosciences, will participate in a fireside chat with Robert Driscoll, Ph.D., Equity ResearchAnalyst, Wedbush, including to discuss his recent industry report entitled "Exploiting Addiction: A Review of Synthetic Lethality in Cancer"
A live audio webcast of each presentation will be available by visiting the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at https://ir.ideayabio.com/news-events/investor-calendar. A replay of the webcasts will be available for 30 days following the live event.
IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including synthetic lethality – which represents an emerging class of precision medicine targets.
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's recent Quarterly Report on Form 10-Q filed on
View original content to download multimedia:http://www.prnewswire.com/news-releases/ideaya-to-participate-in-fireside-chat-at-btig-biotechnology-conference-and-wedbush-pacgrow-healthcare-conference-on-august-11-and-12-2020-301092618.html
Investor and Media Contact: IDEAYA Biosciences, Paul Stone, Chief Financial Officer, email@example.com